Kenta Nakamura
10PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 19, 2024
Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD-1 antibody for BRAF-mutated melanoma.Kenta Nakamura, Tomonori Yaguchi, Masashi Murata
|Nov 11, 2022
Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma.Kenta Nakamura, Ryuhei Okuyama
|Nov 29, 2021
Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma.Kenta Nakamura, Atsuko Ashida, Yukiko Kiniwa
|Mar 26, 2021
CCL5 production by fibroblasts through a local renin-angiotensin system in malignant melanoma affects tumor immune responses.Kenta Nakamura, Yukiko Kiniwa, Ryuhei Okuyama
|Oct 17, 2017
Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment.Kenta Nakamura, Tomonori Yaguchi, Gaku Ohmura
Pageof 2
